1. Home
  2. MRVI vs ECC Comparison

MRVI vs ECC Comparison

Compare MRVI & ECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • ECC
  • Stock Information
  • Founded
  • MRVI 2020
  • ECC N/A
  • Country
  • MRVI United States
  • ECC United States
  • Employees
  • MRVI N/A
  • ECC N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • ECC
  • Sector
  • MRVI Health Care
  • ECC
  • Exchange
  • MRVI Nasdaq
  • ECC NYSE
  • Market Cap
  • MRVI 795.7M
  • ECC 914.2M
  • IPO Year
  • MRVI 2020
  • ECC N/A
  • Fundamental
  • Price
  • MRVI $4.11
  • ECC $8.79
  • Analyst Decision
  • MRVI Buy
  • ECC Buy
  • Analyst Count
  • MRVI 10
  • ECC 2
  • Target Price
  • MRVI $10.28
  • ECC $11.00
  • AVG Volume (30 Days)
  • MRVI 2.4M
  • ECC 679.0K
  • Earning Date
  • MRVI 02-25-2025
  • ECC 02-22-2024
  • Dividend Yield
  • MRVI N/A
  • ECC 19.16%
  • EPS Growth
  • MRVI N/A
  • ECC 369.44
  • EPS
  • MRVI N/A
  • ECC 1.69
  • Revenue
  • MRVI $276,920,000.00
  • ECC $122,654,279.00
  • Revenue This Year
  • MRVI N/A
  • ECC $36.58
  • Revenue Next Year
  • MRVI $1.93
  • ECC $12.88
  • P/E Ratio
  • MRVI N/A
  • ECC $5.93
  • Revenue Growth
  • MRVI N/A
  • ECC 96.41
  • 52 Week Low
  • MRVI $3.93
  • ECC $8.60
  • 52 Week High
  • MRVI $11.56
  • ECC $11.79
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 35.37
  • ECC 49.28
  • Support Level
  • MRVI $4.05
  • ECC $8.69
  • Resistance Level
  • MRVI $4.40
  • ECC $8.96
  • Average True Range (ATR)
  • MRVI 0.31
  • ECC 0.08
  • MACD
  • MRVI -0.05
  • ECC 0.01
  • Stochastic Oscillator
  • MRVI 15.38
  • ECC 51.67

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About ECC EAGLE POINT CREDIT CO LLC

Eagle Point Credit Co Inc is an externally managed, non-diversified closed-end management investment company.

Share on Social Networks: